What is recombinant human interferon α2b suppository?

Oct 20, 2023 Source: Cainiu Health
Dr. Lu Haiying
Introduction
Recombinant human interferon α2b suppository is a medication whose main component is recombinant human interferon α2b. It is commonly used to treat conditions such as cervical columnar epithelial displacement with bacterial infection and cervical intraepithelial neoplasia. The primary mechanism of recombinant human interferon α2b suppository is to inhibit viral growth and replication, while enhancing the body's immune response, thereby achieving the purpose of treating and preventing diseases.

Generally, recombinant human interferon α2b suppositories are an interferon preparation and should be used strictly as directed by a physician. Specific analysis is as follows:

Recombinant human interferon α2b suppositories are a medication whose main active ingredient is recombinant human interferon α2b. They are commonly used to treat conditions such as cervical columnar epithelial displacement with bacterial infection and cervical intraepithelial neoplasia. The primary mechanism of action involves inhibiting viral growth and replication while enhancing the body's immune response, thereby achieving therapeutic and preventive effects against diseases. It is important to note that individuals allergic to this medication should avoid its use to prevent allergic reactions. Additionally, pregnant and breastfeeding women should not use this drug to avoid potential adverse effects on fetal development. If this medication is required, it should only be used under the guidance of a doctor.

During treatment, patients should maintain a light diet and practice proper skin hygiene and care to help enhance the drug's effectiveness.